Circulating-tumour DNA (ctDNA) detection using an ultra-sensitive next generation sequencing (NGS)-based assay in patients with resected colorectal cancer (CRC) in the phase III ASCOLT trial

Daphne Day; Anna  Starus; Oliver Sieber; D Prasse; A Lamik; J Fredebohm; R John Simes; Fiona Day; Robert R. Zielinski; G. Mark Jeffrey; R. Zielinski; M. Singh; G. Cheong; S. Li; John Whay Kuang Chia; Raghib Ali; Hong Chen Toh; Frederick Jones; Eva Segelov

doi:10.1016/j.annonc.2022.04.184

Circulating-tumour DNA (ctDNA) detection using an ultra-sensitive next generation sequencing (NGS)-based assay in patients with resected colorectal cancer (CRC) in the phase III ASCOLT trial

Daphne Day, Anna Starus, Oliver Sieber, D Prasse, A Lamik, J Fredebohm, R John Simes, Fiona Day, Robert R. Zielinski, G. Mark Jeffrey, R. Zielinski, M. Singh, G. Cheong, S. Li, John Whay Kuang Chia, Raghib Ali, Hong Chen Toh, Frederick Jones, Eva Segelov

Medicine Monash Health

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Article number	P-94
Pages (from-to)	S282-S283
Number of pages	2
Journal	Annals of Oncology
Volume	33
Issue number	4
DOIs	https://doi.org/10.1016/j.annonc.2022.04.184
Publication status	Published - 1 Jun 2022

Access to Document

10.1016/j.annonc.2022.04.184

Cite this

Day, D., Starus, A., Sieber, O., Prasse, D., Lamik, A., Fredebohm, J., Simes, R. J., Day, F., Zielinski, R. R., Mark Jeffrey, G., Zielinski, R., Singh, M., Cheong, G., Li, S., Chia, J. W. K., Ali, R., Toh, H. C., Jones, F., & Segelov, E. (2022). Circulating-tumour DNA (ctDNA) detection using an ultra-sensitive next generation sequencing (NGS)-based assay in patients with resected colorectal cancer (CRC) in the phase III ASCOLT trial. Annals of Oncology, 33(4), S282-S283. [P-94]. https://doi.org/10.1016/j.annonc.2022.04.184

@article{083e6e467ef34b02a8eadf740451b35d,

title = "Circulating-tumour DNA (ctDNA) detection using an ultra-sensitive next generation sequencing (NGS)-based assay in patients with resected colorectal cancer (CRC) in the phase III ASCOLT trial",

author = "Daphne Day and Anna Starus and Oliver Sieber and D Prasse and A Lamik and J Fredebohm and Simes, {R John} and Fiona Day and Zielinski, {Robert R.} and {Mark Jeffrey}, G. and R. Zielinski and M. Singh and G. Cheong and S. Li and Chia, {John Whay Kuang} and Raghib Ali and Toh, {Hong Chen} and Frederick Jones and Eva Segelov",

year = "2022",

month = jun,

day = "1",

doi = "10.1016/j.annonc.2022.04.184",

language = "English",

volume = "33",

pages = "S282--S283",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Elsevier BV",

number = "4",

}

Day, D, Starus, A, Sieber, O, Prasse, D, Lamik, A, Fredebohm, J, Simes, RJ, Day, F, Zielinski, RR, Mark Jeffrey, G, Zielinski, R, Singh, M, Cheong, G, Li, S, Chia, JWK, Ali, R, Toh, HC, Jones, F & Segelov, E 2022, 'Circulating-tumour DNA (ctDNA) detection using an ultra-sensitive next generation sequencing (NGS)-based assay in patients with resected colorectal cancer (CRC) in the phase III ASCOLT trial', Annals of Oncology, vol. 33, no. 4, P-94, pp. S282-S283. https://doi.org/10.1016/j.annonc.2022.04.184

Circulating-tumour DNA (ctDNA) detection using an ultra-sensitive next generation sequencing (NGS)-based assay in patients with resected colorectal cancer (CRC) in the phase III ASCOLT trial. / Day, Daphne; Starus, Anna ; Sieber, Oliver et al.

In: Annals of Oncology, Vol. 33, No. 4, P-94, 01.06.2022, p. S282-S283.

Research output: Contribution to journal › Meeting Abstract › peer-review

TY - JOUR

T1 - Circulating-tumour DNA (ctDNA) detection using an ultra-sensitive next generation sequencing (NGS)-based assay in patients with resected colorectal cancer (CRC) in the phase III ASCOLT trial

AU - Day, Daphne

AU - Starus, Anna

AU - Sieber, Oliver

AU - Prasse, D

AU - Lamik, A

AU - Fredebohm, J

AU - Simes, R John

AU - Day, Fiona

AU - Zielinski, Robert R.

AU - Mark Jeffrey, G.

AU - Zielinski, R.

AU - Singh, M.

AU - Cheong, G.

AU - Li, S.

AU - Chia, John Whay Kuang

AU - Ali, Raghib

AU - Toh, Hong Chen

AU - Jones, Frederick

AU - Segelov, Eva

PY - 2022/6/1

Y1 - 2022/6/1

U2 - 10.1016/j.annonc.2022.04.184

DO - 10.1016/j.annonc.2022.04.184

M3 - Meeting Abstract

VL - 33

SP - S282-S283

JO - Annals of Oncology

JF - Annals of Oncology

SN - 0923-7534

IS - 4

M1 - P-94

ER -